PR Newswire BiotechnologyQwen · 实盘不做把握 1/10不做原因:不是事件🔁 +1 同一事件
北京时间·🕒 发布 20:00:00·⟳ 抓取 20:00:39 +39s·⚡ 决策 08-31 20:33:00 +32m21s·57.0 天前
AbbVie宣布将于9月9日参加Wells Fargo第21届年度医疗健康会议并进行炉边对话
这是一条标准的投资者会议参与公告（conference participation announcement），仅告知管理层将在9天后的一次行业会议上进行炉边对话。没有新的业务数据、产品进展、管线更新、指引变化或任何可能改变市场预期的增量信息。大型药企每年参加数十次投资者会议，此类公告对股价无任何催化作用。
📄 原文PR Newswire Biotechnology↗ 原文
AbbVie to Present at the Wells Fargo 21st Annual Healthcare Conference
NORTH CHICAGO, Ill., Aug. 31, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Wells Fargo 21st Annual…
不做 AbbVie（ABBV.US）
例行投资者会议参与公告，无新增业务信息、无指引变化、无产品/管线催化，不构成任何方向性交易机会。会议尚未发生（9月9日），即使届时管理层发言也属常规交流，当前无可交易edge。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
AbbVie通过PR Newswire发布例行公告，宣布将于2026年9月9日参加Wells Fargo医疗健康会议并进行炉边对话。这是标准的IR活动预告，不包含任何新增业务信息、财务指引或管线进展。会议本身尚未发生，即使发生也仅为管理层与投资者的常规交流，不构成可交易催化。
🔎 新鲜度:最早出现 2026-08-31 · 扩散 low · price-in 风险 low ↗
先例如何影响了这次决策
对本次决策的影响:无需先例校准，事件本身不具备催化属性
方向:无适用先例——投资者会议参与公告不构成可交易事件类别
涨幅量级:不适用
形态:不适用
原文全文
展开原文 · 1,098 字
AbbVie to Present at the Wells Fargo 21st Annual Healthcare Conference
NORTH CHICAGO, Ill., Aug. 31, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026. Management will participate in a fireside chat at 9:15 a.m. Central time.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.
Media: Catherine Langel |
Investors: Liz Shea |
SOURCE AbbVie
NORTH CHICAGO, Ill., Aug. 31, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026. Management will participate in a fireside chat at 9:15 a.m. Central time.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.
Media: Catherine Langel |
Investors: Liz Shea |
SOURCE AbbVie
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。